---
figid: PMC9701826__fgene-13-1067254-g003
pmcid: PMC9701826
image_filename: fgene-13-1067254-g003.jpg
figure_link: /pmc/articles/PMC9701826/figure/F3/
number: FIGURE 3
figure_title: ''
caption: Immune landscape description of the high- and low-risk groups. (A) Six-gene
  expression in the high- and low-risk groups. (B) Six-gene expression and immune
  cell correlation analysis. (C) Immunocellular infiltration comparison of high- and
  low-risk groups. (D) Comparison of immune behavior in the high- and low-risk groups.
  (E) Pathway enrichment analysis by GSVA between the high-risk and low-risk groups.
  (F) Gene Ontology (GO) analysis of the high-risk group based on the gene set enrichment
  analysis (GSEA) results. (G) GO analysis of the low-risk group based on the GSEA
  results. (H) stromal, immune, and ESTIMATE scores in the high- and low-risk groups.
article_title: Identification of immune-related signature for the prognosis and benefit
  of immunotherapy in triple-negative breast cancer.
citation: Xiaorui Sun, et al. Front Genet. 2022;13:1067254.
year: '2022'

doi: 10.3389/fgene.2022.1067254
journal_title: Frontiers in Genetics
journal_nlm_ta: Front Genet
publisher_name: Frontiers Media S.A.

keywords:
- triple-negative breast cancer
- immune risk score
- immune therapy
- tumor microenvironment
- biomarker

---
